Benitec Lays Off Half of US Staff, Trims Drug-Development Programs in Cost-Cutting Effort | GenomeWeb

NEW YORK, April 18 (GenomeWeb News) - Benitec said today that it has cut its US workforce in half in an effort to reduce the operational expenses of its US subsidiary.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.